Advertisement

Fresenius Kabi AG Company Profile

07:56 EDT 23rd May 2013 | BioPortfolio

Fresenius Kabi is the leader in Infusion Therapy and Clinical Nutrition in Europe and in its most important countries of Latin America and Asia Pacific. In addition, we are active in the field of Transfusion Technology, supplying blood processing systems as well as blood bags and filters. We are focused on the therapy and care of critically and chronically ill patients in and outside the hospital.

Location

Bad Homburg v.d.H.
61346
Germany

Contact

Phone: 49 6172 686 0
Fax: 49 6172 686 2628


News Articles [ 240 Associated News Articles listed on BioPortfolio]

Fresenius Kabi buys Fenwal in transfusion push

FRANKFURT, July 20 (Reuters) - Fresenius Se on Friday said Fresenius Kabi had signed a definitive agreement to acquire Fenwal Holdings Inc. for an undisclosed amount from TPG and Maverick Capital.

Fresenius to divest antibody and biotech business

The Fresenius Group has said it is to discontinue its Fresenius Biotech subsidiary, focusing instead on four other business segments; Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Frese...

Fresenius Kabi sells respiratory homecare business in France

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement to sell its subsidiary Calea France SAS to German technology firm The Linde Group. Calea is...

Fresenius to discontinue biotech subsidiary

Fresenius, a health care group with international operations, has decided to discontinue its subsidiary Fresenius Biotech. Instead, the company will focus on its four established business segments Fre...

Fresenius Kabi launches Acetylcysteine Solution, USP, 20%

Fresenius Kabi USA has announced the availability of Acetylcysteine Solution, USP, 20% 30ml vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote) to treat lung diseases...

Fresenius lifts Kabi unit's outlook for 3rd time

FRANKFURT, Sept 5 (Reuters) - German healthcare conglomerate Fresenius raised the full-year profit outlook for its generic infusion drug unit Kabi for the third time this year as it benefits from riva...

Fresenius Kabi to purchase Fenwal

Fresenius Kabi has entered into a definitive agreement to purchase Fenwal, a provider of separation technologies for blood and cell collection and therapy.

UPDATE 1-Fresenius Kabi buys blood equipment maker Fenwal

* Fresenius continues to assess options for Rhoen-Klinikum

Drugs and Medications [ 13 Associated Drugs and Medications listed on BioPortfolio]

Intralipid 20%a 20% i.v. fat emulsion in excel container [Fresenius Kabi AB]

Intralipid 20%A 20% I.V. Fat Emulsion In Excel Container

Intralipid 10%a 10% i.v. fat emulsion in excel container [Fresenius Kabi AB]

Intralipid 10%A 10% I.V. Fat Emulsion In Excel Container

Intralipid 20%a 20% i.v. fat emulsion in excel container [Fresenius Kabi AB]

Intralipid 20%A 20% I.V. Fat Emulsion In Excel Container

Intralipid [Baxter Healthcare Corporation]

Intralipid 30%

Hetastarch [Teva Parenteral Medicines, Inc]

6% Hetastarch In 0.9% Sodium Chloride Injection

PubMed Articles [ 17 Associated PubMed Articles listed on BioPortfolio]

Biomaterials in medical devices: An Interview with Jörg Vienken of Fresenius Medical Care, Germany.

Biomaterial and biopolymer research have significant impact on the development as well as application of biotechnology. Biotechnology Journal recently attended the "Nanomaterials for Biomedical Techno...

Body fat and fat-free mass measured by bioelectric impedance spectroscopy and dual-energy X-ray absorptiometry in obese and non-obese adults.

The aim of the present study was to compare body fat mass (FM) and fat-free mass (FFM) estimates by bioelectric impedance spectroscopy (BIS), with respective estimates by dual-energy X-ray absorptiome...

The interaction of chitosan and olive oil: effects of degree of deacetylation and degree of polymerization.

The combined effects of degree of deacetylation (DD) and degree of polymerization (DP) on the ability of chitosan to interact with olive oil was studied. The oil-binding test, a method that makes use...

Blood leak alarm interference by hydoxocobalamin is hemodialysis machine dependent.

Context. Hydroxocobalamin has been reported to interfere with the blood leak alarm on hemodialysis machines making it difficult to use this treatment modality after hydroxocobalamin infusion. Objectiv...

Intravenous omega-3, a technique to prevent an excessive innate immune response to cardiac surgery in a rodent gut ischemia model.

OBJECTIVES: Neutrophil infiltration of tissues as part of the inflammatory response to cardiac surgery is one of the major mediators of postoperative multiple-organ dysfunction. Omega-3 fatty acids ma...

Clinical Trials [ 13 Associated Clinical Trials listed on BioPortfolio]

Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)

The primary hypothesis constitutes that the fish-oil preparation (Omegaven) is superior to the preparation based on Soja-oil (Lipovenös)to reduce signs and symptoms in patients with activ...

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

The study aim is to evaluate the influence of the anti-T-lymphocyte globulin ATG-Fresenius S given pre-transplant in addition to standard GvHD prophylaxis with cyclosporine A and a short c...

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines

This is a mono-center randomized controlled trial to be performed in the Center of Medical Research (ZMF) at Medical University Graz and is composed by one screening visit (V1) and two stu...

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Paediatric patients affected by haematological malignancies and eligible to undergo HSCT from an unrelated volunteer will be stratified according to the degree of compatibility with their...

Comparison of ATG to Thymoglobuline in Renal Transplantation

An open, multicenter, randomised, parallel group pilot study to investigate two different polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of ATG-Freseni...

Companies [ 12 Associated Companies listed on BioPortfolio]

Fresenius Kabi USA, LLC

Fresenius Kabi is focused on the care of critically and chronically ill patients inside and outside the hospital. Its portfolio of products comprises a wide range of IV drugs, inf...

Fresenius AG

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.The Fresenius Group consists of the following three business segm...

Fresenius Kabi AG

Fresenius Kabi is the leader in Infusion Therapy and Clinical Nutrition in Europe and in its most important countries of Latin America and Asia Pacific. In addition, we are active in the field of Tran...

Fresenius Medical Care North America

Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest integrated provider of products and services for individuals unde...

Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care is the world's largest, integrated provider of products and services for individuals with chronic kidney failure, a condition that affects more than 1,400,000 individuals worldw...

More Information about "Fresenius Kabi AG" on BioPortfolio

We have published hundreds of Fresenius Kabi AG news stories on BioPortfolio along with dozens of Fresenius Kabi AG Clinical Trials and PubMed Articles about Fresenius Kabi AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fresenius Kabi AG Companies in our database. You can also find out about relevant Fresenius Kabi AG Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement